A Day Up For Atossa Therapeutics, Inc.
Mon, Jun 07, 2021 at 05:33 PM
Atossa Therapeutics, Inc. (ATOS:NASDAQ) shot up at $6.01, a gain of 30.1%. On Fri, Jun 04, 2021, ATOS:NASDAQ hit a New 2-Week High of $4.62. The stock got featured on our News Catalysts scanner on Mon, Jun 07, 2021 at 09:09 AM in the 'BIOTECH' category. From Fri, May 21, 2021, the stock recorded 77.78% Up Days and 60.00% Green Days
About Atossa Therapeutics, Inc. (ATOS:NASDAQ)
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Top 10 Gainers:
- Ra Medical Systems, Inc. (RMED:NYSE), 87.3%
- EXFO Inc. (EXFO:NASDAQ), 60.27%
- NextDecade Corporation (NEXT:NASDAQ), 42.62%
- Biogen Inc. (BIIB:NASDAQ), 38.34%
- Urban One, Inc. (UONE:NASDAQ), 35.6%
- CLOV (CLOV:NASDAQ), 32.44%
- Vaccinex, Inc. (VCNX:NASDAQ), 30.43%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 30.09%
- Prothena Corporation plc (PRTA:NASDAQ), 29.95%
- U.S. Concrete, Inc. (USCR:NASDAQ), 29.28%